Literature DB >> 17926345

22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.

Kristina Cusmano-Ozog1, Melanie A Manning, H Eugene Hoyme.   

Abstract

The 22q13.3 deletion syndrome is a recognizable malformation syndrome associated with developmental delay, hypotonia, delayed or absent speech, autistic-like behavior, normal to accelerated growth and dysmorphic facies. The prevalence of this disorder is unknown, but it is likely under-diagnosed. Age at diagnosis has varied widely, from cases diagnosed prenatally to 46 years. Males and females are equally affected. The distal 22q deletion can be detected occasionally by routine or high resolution chromosome analysis; however, the majority of cases are detected by FISH analysis, associated with deletion of the ARSA (control) probe when performing a FISH analysis for the velocardiofacial syndrome (del 22q11.2). The 22q13.3 deletion syndrome can accompany a simple chromosome deletion, an unbalanced translocation, or a ring chromosome. Primary care physicians, in addition to numerous specialists, play an important role in caring for patients with this disorder. Although the dysmorphic features observed in this condition are nonspecific, it is an important consideration in the differential diagnosis of children with developmental delay, hypotonia, marked speech and language disability, autistic-like features, multiple minor anomalies, and normal growth and head circumference. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17926345     DOI: 10.1002/ajmg.c.30155

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  30 in total

1.  Clinical utility gene card for: deletion 22q13 syndrome.

Authors:  Katy Phelan; Catalina Betancur
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

2.  Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.

Authors:  Gilles Droogmans; Ann Swillen; Griet Van Buggenhout
Journal:  Mol Syndromol       Date:  2019-11-05

Review 3.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 4.  Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.

Authors:  Ece D Gamsiz; Laura N Sciarra; Abbie M Maguire; Matthew F Pescosolido; Laura I van Dyck; Eric M Morrow
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

5.  22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.

Authors:  S U Dhar; D del Gaudio; J R German; S U Peters; Z Ou; P I Bader; J S Berg; M Blazo; C W Brown; B H Graham; T A Grebe; S Lalani; M Irons; S Sparagana; M Williams; J A Phillips; A L Beaudet; P Stankiewicz; A Patel; S W Cheung; T Sahoo
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

6.  Phelan-McDermid syndrome presenting with autistic spectrum: are we underdiagnosing chromosomal diseases in patients with autism?

Authors:  Wladimir Bocca Vieira de Rezende Pinto; José Luiz Pedroso; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-09-29       Impact factor: 4.849

Review 7.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

8.  The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss-of-function mutations.

Authors:  J Lloyd Holder; Michael M Quach
Journal:  Epilepsia       Date:  2016-08-24       Impact factor: 5.864

9.  Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation.

Authors:  Ye Wu; Taoyun Ji; Jingmin Wang; Jing Xiao; Huifang Wang; Jie Li; Zhijie Gao; Yanling Yang; Bin Cai; Liwen Wang; Zhongshu Zhou; Lili Tian; Xiaozhu Wang; Nan Zhong; Jiong Qin; Xiru Wu; Yuwu Jiang
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

10.  Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex.

Authors:  Martin Poot; Marc J Eleveld; Ruben van 't Slot; Hans Kristian Ploos van Amstel; Ron Hochstenbach
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.